SECURITIES AND UNITED STATES
EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 10, 2004
SURGICARE, INC.
---------------
(Exact name of registrant as specified in its charter)
DELAWARE 001-16587 58-1597246
-------- ------- ----------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
12727 Kimberley Lane, Suite 200
Houston, Texas 77024
--------------------
(Address of principal executive offices, including zip code)
(713) 973-6675
--------------
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if change since last report)
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE.
On May 10, 2004, Surgicare, Inc. announced that on April 27, 2004, it filed
amended preliminary proxy materials with the Securities and Exchange Commission.
Reference is made to the press release filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
99.1 Press Release of SurgiCare, Inc. issued May 10, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SURGICARE, INC.
By: /s/ KEITH G. LEBLANC
----------------------------------
Name: Keith G. LeBlanc
Title: Chief Executive Officer
Dated: May 10, 2004